$2.04 Million is the total value of Boxer Capital, LLC's 75 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 16.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXDX | Prometheus Biosciences Inc | $203,640 | -99.9% | 1,897,500 | 0.0% | 10.00% | -9.1% | |
| RETA | Reata Pharmaceuticals Inccl a | $111,832 | -99.8% | 1,230,004 | 0.0% | 5.49% | +123.1% | |
| BGNE | BeiGene Ltdsponsored adr | $107,765 | -99.9% | 500,000 | 0.0% | 5.29% | -8.7% | |
| SRPT | New | Sarepta Therapeutics Inc | $106,818 | – | 775,000 | +100.0% | 5.25% | – |
| APLS | Apellis Pharmaceuticals Inc | $103,953 | -99.9% | 1,576,000 | 0.0% | 5.11% | +18.9% | |
| Tyra Biosciences Inc | $103,625 | -99.8% | 6,448,359 | 0.0% | 5.09% | +97.0% | ||
| RVMD | Buy | Revolution Medicines Inc | $101,461 | -99.9% | 4,684,264 | +17.6% | 4.98% | -0.4% |
| SWTX | Springworks Therapeutics Inc | $88,070 | -99.9% | 3,421,541 | 0.0% | 4.33% | -7.8% | |
| MRTX | Mirati Therapeutics Inc | $74,360 | -99.9% | 2,000,000 | 0.0% | 3.65% | -23.5% | |
| CYTK | Cytokinetics Inc | $73,899 | -99.9% | 2,100,000 | 0.0% | 3.63% | -28.4% | |
| Amylyx Pharmaceuticals Inc | $61,145 | -99.9% | 2,084,000 | 0.0% | 3.00% | -26.0% | ||
| SAGE | Sage Therapeutics Inc | $45,904 | -99.9% | 1,094,000 | 0.0% | 2.26% | +2.5% | |
| SGEN | New | Seagen Inc | $40,494 | – | 200,000 | +100.0% | 1.99% | – |
| RLAY | Relay Therapeutics Inc | $35,726 | -99.9% | 2,169,132 | 0.0% | 1.76% | +2.8% | |
| MRUS | Merus N V | $34,960 | -99.9% | 1,900,000 | 0.0% | 1.72% | +10.8% | |
| VKTX | Buy | Viking Therapeutics Inc | $33,300 | -99.8% | 2,000,000 | +33.3% | 1.64% | +120.2% |
| ETNB | Buy | 89Bio Inc | $31,983 | -99.8% | 2,100,000 | +50.0% | 1.57% | +67.1% |
| AKRO | Akero Therapeutics Inc | $31,813 | -99.9% | 831,495 | 0.0% | 1.56% | -34.9% | |
| Nuvalent Inc | $31,574 | -99.9% | 1,210,192 | 0.0% | 1.55% | -18.4% | ||
| IDYA | Ideaya Biosciences Inc | $30,245 | -99.9% | 2,202,812 | 0.0% | 1.49% | -29.6% | |
| ITOS | iTeos Therapeutics Inc | $29,317 | -99.9% | 2,154,058 | 0.0% | 1.44% | -35.1% | |
| Ventyx Biosciences Inc | $28,475 | -99.9% | 850,000 | 0.0% | 1.40% | -4.8% | ||
| ANAB | AnaptysBio Inc | $28,288 | -99.9% | 1,300,000 | 0.0% | 1.39% | -34.6% | |
| Tango Therapeutics Inc | $28,138 | -99.9% | 7,123,642 | 0.0% | 1.38% | -49.2% | ||
| RCUS | Arcus Biosciences Inc | $26,123 | -99.9% | 1,432,200 | 0.0% | 1.28% | -17.8% | |
| FOLD | Amicus Therapeutics Inc | $25,784 | -99.9% | 2,325,000 | 0.0% | 1.27% | -15.4% | |
| RCKT | Rocket Pharmaceuticals Inc | $25,113 | -99.9% | 1,466,051 | 0.0% | 1.23% | -18.4% | |
| AXSM | Axsome Therapeutics Inc | $24,672 | -99.9% | 400,000 | 0.0% | 1.21% | -25.5% | |
| BLU | Bellus Health Inc New | $23,040 | -99.9% | 3,200,000 | 0.0% | 1.13% | -18.4% | |
| IOVA | Buy | Iovance Biotherapeutics Inc | $22,638 | -99.8% | 3,705,133 | +146.2% | 1.11% | +119.3% |
| EXEL | Exelixis Inc | $22,322 | -99.9% | 1,150,000 | 0.0% | 1.10% | +12.9% | |
| XENE | Xenon Pharmaceuticals Inc | $21,474 | -99.9% | 600,000 | 0.0% | 1.06% | -15.4% | |
| ISEE | Iveric Bio Inc | $20,072 | -99.9% | 825,000 | 0.0% | 0.99% | +5.9% | |
| RAIN | Rain Oncology Inc | $18,767 | -99.9% | 2,147,212 | 0.0% | 0.92% | +1.8% | |
| PNT | Point Biopharma Global Inc | $18,175 | -99.9% | 2,500,000 | 0.0% | 0.89% | -7.1% | |
| RNA | Avidity Biosciences Inc | $17,212 | -99.9% | 1,121,327 | 0.0% | 0.85% | -35.5% | |
| DAWN | Day One Biopharmaceuticals I | $15,910 | -99.9% | 1,189,943 | 0.0% | 0.78% | -42.1% | |
| New | Enliven Therapeutics Inc | $15,563 | – | 710,644 | +100.0% | 0.76% | – | |
| PMVP | PMV Pharmaceuticals Inc | $15,091 | -99.9% | 3,163,795 | 0.0% | 0.74% | -48.9% | |
| PRTA | Prothena Corp PLC | $14,541 | -99.9% | 300,000 | 0.0% | 0.71% | -25.1% | |
| KALV | New | Kalvista Pharmaceuticals Inc | $12,969 | – | 1,650,000 | +100.0% | 0.64% | – |
| CGEM | Cullinan Oncology Inc | $10,988 | -99.9% | 1,074,082 | 0.0% | 0.54% | -9.5% | |
| NRIX | Nurix Therapeutics Inc | $10,877 | -99.9% | 1,224,892 | 0.0% | 0.53% | -24.7% | |
| ASND | Ascendis Pharma A/Ssponsored adr | $10,186 | -99.9% | 95,000 | 0.0% | 0.50% | -18.3% | |
| MORF | New | Morphic Hldg Inc | $7,528 | – | 200,000 | +100.0% | 0.37% | – |
| ORIC | Oric Pharmaceuticals Inc | $6,008 | -99.9% | 1,054,000 | 0.0% | 0.30% | -24.0% | |
| COGT | Cogent Biosciences Inc | $5,665 | -99.9% | 525,000 | 0.0% | 0.28% | -13.1% | |
| RAPT | New | Rapt Therapeutics Inc | $5,505 | – | 300,000 | +100.0% | 0.27% | – |
| PANA | Panacea Acquisition Corp II | $5,110 | -99.9% | 500,000 | 0.0% | 0.25% | -23.2% | |
| New | Orchestra Biomed Hldgs Inc | $4,893 | – | 250,000 | +100.0% | 0.24% | – | |
| CNTA | Centessa Pharmaceuticals PLCsponsored ads | $4,817 | -100.0% | 1,251,137 | 0.0% | 0.24% | -88.4% | |
| 2Seventy Bio Inc | $4,690 | -99.9% | 459,836 | 0.0% | 0.23% | +1.3% | ||
| SELB | Selecta Biosciences Inc | $4,565 | -99.9% | 3,284,072 | 0.0% | 0.22% | +14.3% | |
| CABA | Cabaletta Bio Inc | $4,466 | -99.9% | 540,000 | 0.0% | 0.22% | -16.7% | |
| GOSS | Gossamer Bio Inc | $4,205 | -99.9% | 3,336,928 | 0.0% | 0.21% | -45.8% | |
| PRLD | New | Prelude Therapeutics Inc | $3,985 | – | 699,047 | +100.0% | 0.20% | – |
| BDTX | Black Diamond Therapeutics I | $3,808 | -99.9% | 2,014,858 | 0.0% | 0.19% | -2.1% | |
| KNTE | Kinnate Biopharma Inc | $3,188 | -99.9% | 510,000 | 0.0% | 0.16% | -4.3% | |
| Sell | Theseus Pharmaceuticals Inc | $3,108 | -99.8% | 350,000 | -15.7% | 0.15% | +40.4% | |
| FATE | Sell | Fate Therapeutics Inc | $2,850 | -100.0% | 500,000 | -60.0% | 0.14% | -78.9% |
| MIST | Milestone Pharmaceuticals In | $2,754 | -99.9% | 698,861 | 0.0% | 0.14% | -7.5% | |
| Disc Medicine Inc | $2,755 | -98.4% | 130,000 | 0.0% | 0.14% | +1400.0% | ||
| BCEL | Atreca Inc | $2,511 | -99.9% | 2,202,333 | 0.0% | 0.12% | +32.3% | |
| DBVT | DBV Technologies S Asponsored adr | $2,451 | -99.9% | 1,450,000 | 0.0% | 0.12% | +2.6% | |
| Third Harmonic Bio Inc | $2,350 | -99.9% | 570,417 | 0.0% | 0.12% | -10.9% | ||
| NGM | NGM Biopharmaceuticals Inc | $2,040 | -99.9% | 500,000 | 0.0% | 0.10% | -24.2% | |
| EQRx Inc | $1,940 | -99.9% | 1,000,000 | 0.0% | 0.10% | -26.9% | ||
| BCAB | BioAtla Inc | $1,839 | -100.0% | 686,347 | 0.0% | 0.09% | -69.9% | |
| MREO | Mereo Biopharma Group PLCspon ads | $1,591 | -99.9% | 2,250,000 | 0.0% | 0.08% | -12.4% | |
| ZIOP | Alaunos Therapeutics Inc | $945 | -99.9% | 1,500,000 | 0.0% | 0.05% | -9.8% | |
| MEIP | MEI Pharma Inc | $667 | -99.9% | 2,913,091 | 0.0% | 0.03% | -10.8% | |
| TARA | Protara Therapeutics Inc | $655 | -99.9% | 209,227 | 0.0% | 0.03% | +6.7% | |
| VERU | Veru Inc | $403 | -100.0% | 347,300 | 0.0% | 0.02% | -79.4% | |
| NUVBWS | Nuvation Bio Inc*w exp 07/07/202 | $32 | -99.9% | 266,666 | 0.0% | 0.00% | 0.0% | |
| Surrozen Inc*w exp 08/01/203 | $4 | -99.9% | 66,666 | 0.0% | 0.00% | – | ||
| Exit | Bellicum Pharmaceuticals Inc | $0 | – | -56,950 | -100.0% | -0.00% | – | |
| HSAQ | Exit | Health Sciences Acq Corp 2 | $0 | – | -250,000 | -100.0% | -0.13% | – |
| ARVN | Exit | Arvinas Inc | $0 | – | -150,000 | -100.0% | -0.27% | – |
| GERN | Exit | Geron Corp | $0 | – | -8,100,000 | -100.0% | -1.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| iTeos Therapeutics, Inc. | May 11, 2022 | 2,154,058 | 6.1% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
| SC 13D/A | 2024-01-25 |
| SC 13G | 2024-01-18 |
| SC 13D/A | 2023-12-18 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.